DEBORAH MOORE: Open Payments
NPI 1285700443 · CORINTH, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$302 in 17 payments from 6 companies in 2025. Trend: 2023 $758 · 2024 $462 · 2025 $302
Food & beverage: $302
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 7 | $119 |
| AstraZeneca Pharmaceuticals LP | 3 | $57 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $40 |
| ABBVIE INC. | 2 | $34 |
| Axsome Therapeutics, Inc. | 2 | $32 |
| Lundbeck LLC | 1 | $21 |
Products named: Wegovy, CAPLYTA, BREZTRI, Auvelity, REXULTI, UBRELVY, Ozempic, VRAYLAR.
Industry payments across MS — which companies pay providers there.
